21st International Conference on Alzheimer's Drug Discovery
This annual conference showcased the innovative approaches of Alzheimer’s Drug Discovery Foundation’s (ADDF) funded scientists and their newest results. In addition to featuring ADDF’s portfolio, the program also included guest presentations focusing on the latest research in the Alzheimer’s disease field.
The program featured five sessions:
- Novel Approaches for Neuroinflammation
- Metabolic and Mitochondrial Approaches for Alzheimer’s Disease
- Emerging Areas in Drug Development for Neurodegeneration
- Neuroprotection, Synaptic Health and Neurotransmitters
- Novel Biomarkers in Alzheimer’s Disease
The registration for this conference will be free though a brief form available at the Registration page.
- Highlight scientific progress on drug development and biomarker programs aimed at treating Alzheimer’s disease and related dementias.
- Increase opportunities for early career investigators and start-up companies to share information and resources.
- Foster interdisciplinary and public-private partnerships and alliances.
Virtual Poster Presentations
Ample sponsorship opportunities
The purpose for this annual ADDF conference is to accelerate the development of innovative treatments for Alzheimer’s disease, related dementias and cognitive aging.
Attendees will see the diverse cutting-edge approaches ADDF scientists are undertaking and have opportunities for networking and partnership discussions with academic, industry, and foundation thought leaders.
The 2020 edition of this conference attracted close to 900 attendees from around the world. Attendees included:
- Academic and industry scientists engaged in drug discovery and biomarker research for neurodegenerative diseases and CNS
- Business development and licensing professionals
- Alliance management professionals
- Venture capitalists and other investors
- Graduate students, PhD candidates and post-doctoral fellows.
SPEAKERS AND CHAIRS
Weill Cornell MC
UC San Diego
Burke Neuro. Inst
NS Kline Inst.
Johns Hopkins U.
The Rockefeller Univ.
Linda Van Eldik
Univ. of Kentucky
Univ. of Gothenburg